AstraZeneca
- Home
- Companies
- AstraZeneca
- Products
- Model AZD1390 Phase I - Glioblastoma
Model AZD1390 Phase I -Glioblastoma
FromAstraZeneca
Mechanism: ATM inhibitor; Area under investigation: glioblastoma; Date commenced phase: Q2 2018; Estimated Filing Acceptance: US: EU: Japan: China. Additional information. Molecule size: Small molecule Status change.
